Humedix financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩0.00M | ₩42.13B | ₩47.13B | ₩54.73B | ₩64.83B | ₩78.62B | ₩98.48B | ₩110.99B | ₩0.00M | ₩0.00M | ₩0.00M |
| GM % | Gross Margin % |
|
0.00% | 51.43% | 47.69% | 44.93% | 39.52% | 41.72% | 40.00% | 39.70% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 33.35% | 27.24% | 22.68% | 16.49% | 16.89% | 16.90% | 14.41% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
₩1.59k | ₩1.22k | ₩2.61k | ₩0.00 | |||||||
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩400.00 | ₩400.00 | ₩0.00 | ₩600.00 | ₩0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 25.20% | 32.68% | 0 | 23.01% | 0 |
| Sha. | Shares |
|
7.82m | 9.92m | 9.92m | 9.83m | 9.64m | 9.52m | 9.49m | 9.4m | 9.12m | 10.35m | 10.38m |
| OCF | Operating Cash Flow |
|
₩0.00M | ₩11.71B | ₩7.61B | ₩8.77B | ₩23.80B | ₩13.81B | ₩23.76B | ₩19.18B | ₩0.00M | ₩0.00M | ₩0.00M |
| FCF | Free Cash Flow |
|
₩0.00M | ₩1.03B | ₩-14752.60M | ₩-10633.88M | ₩10.82B | ₩4.48B | ₩6.07B | ₩5.44B | ₩0.00M | ₩32.00B | ₩0.00M |
| FCFS | Free Cash Flow Per Share |
|
₩0.00 | ₩94.02 | ₩-1569.89 | ₩-1182.79 | ₩735.88 | ₩469.13 | ₩638.70 | ₩472.31 | ₩0.00 | ₩0.00 | ₩0.00 |